Trans-sialidase delivered as a naked DNA vaccine elicits an immunological response similar to a Trypanosoma cruzi infection
Trypanosoma cruzi, the protozoan parasite that causes Chagas' disease, does not synthesize sialic acid, but expresses a trans-sialidase (TS) that catalyzes the transfer of sialic acid from host glycoconjugates to the parasite surface. Here, we review studies that characterize the immune response to the catalytic domain of the enzyme in humans during Chagas' disease or in mice following immunization with the TS gene. In both cases, there are antibodies that strongly inhibit the enzymatic activity and generation of interferon-<FONT FACE="Symbol">g</FONT>-producing T cells.
Guardado en:
Autores principales: | Costa,F., Pereira-Chioccola,V.L., Ribeirão,M., Schenkman,S., Rodrigues,M.M. |
---|---|
Formato: | Digital revista |
Idioma: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
1999
|
Acceso en línea: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X1999000200013 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The non-palindromic adaptor-PCR method for the identification of the T-cell receptor genes of an interferon-gamma-secreting T-cell hybridomaspecific for trans-sialidase, an immunodominant Trypanosoma cruzi antigen
por: Hiyane,M.I., et al.
Publicado: (2006) -
A Therapeutic Oral Vaccine Candidate against Propionibacterium acnes: Preparation and Immunological Evaluation of Nanoparticles Encapsulated Sialidase-CAMP Fusion Protein
por: Parvin,Zargham, et al.
Publicado: (2020) -
Immunological properties of gene vaccines delivered by different routes
por: Oliveira,S.C., et al.
Publicado: (1999) -
Trypanosoma rangeli sialidase: lack of activity in stocks from Panama and other regions
por: Sousa,Octavio E, et al.
Publicado: (2005) -
CC-chemokine receptors: a potential therapeutic target for Trypanosoma cruzi-elicited myocarditis
por: Marino,APMP, et al.
Publicado: (2005)